Table 1. Pretransplantation Clinical Profile of the Patients in the Study and Control Group.
FK 506 | CyA | |
---|---|---|
Number | 59 | 50 |
Median age | 2.7 years (0.2 to 16.5) | 1.8 years (0.3 to 15.2) |
Male/female | 31/28 | 22/28 |
Cholestatic liver disease | 38 | 36 |
A-1-A | 3 | 3 |
Neonatal hepatitis | 5 | 2 |
Cystic fibrosis | 3 | 2 |
Fulminant hepatitis | 2 | 2 |
Hepatoblastoma | 2 | 2 |
All others | 6 | 2 |
Previous Kasai | 30 | 28 |
PRA > 10% | 4 | 4 |
Gross × (+) | ||
Strongly | 1 | 4 |
Weakly | 10 | 4 |